Regulation & Compliance

SurgePays is building a powerful AI to serve 138 million subprime consumers. But as we chase innovation, we must ask: is this the path to equity or a new digital trap?

A new report reveals a staggering $1.77 trillion societal cost from crashes. Beyond the stats lies a story of behavioral shifts and systemic failures.

South Korean tech giant KakaoStyle launches its AI-powered K-Beauty platform, PIYONNA, in France, betting on authenticity and big data to conquer Europe.

A landmark deal between XTransfer and Societe Generale signals more than a partnership; it’s a strategic blueprint to fix the broken plumbing of global trade finance.

The 2026 Global Forex Awards are out, but the real story isn't just who won. It's how the winners map the future of finance, technology, and trust.

The insurance industry is all-in on AI, but a recent NYC conference revealed a critical flaw: the technology is only as good as the messy data it runs on.

Julie Mueller's move to acquire 100% of Custom Design Benefits isn't just a transaction; it's a strategic bet on independence in a consolidating market.

Interim Phase 3 data shows Otsuka's VOYXACT not only meets surrogate endpoints but preserves kidney function, a strategic masterstroke in the competitive nephrology market.

A French firm is using a special economic zone to bypass China's tough regulations. Is its scarless vein treatment a medical breakthrough or a brilliant market hack?

Sooner Insurance’s top rating reveals a powerful strategy. Discover how giants like ConocoPhillips use captive insurers as a secret weapon for financial stability.

From exploding cameras to hazardous baby products, a massive wave of recalls exposes hidden dangers in everyday items. Here's what you need to know.

After addressing transparency concerns raised by Rep. Fitzgerald, indie-focused PRO AllTrack agrees to new measures, signaling shifts in music rights and the looming debate on AI.

A new alliance between Made Scientific and Pluristyx promises to slash the time and cost of developing advanced iPSC therapies. But can it deliver on its promise?

Pivotal data on zilurgisertib offers hope for FOP patients, as Mirum and Incyte navigate a fast-track FDA review for this groundbreaking ALK2 inhibitor.

A new partnership between FusionAIrre and Schneider Downs uses agentic AI to overhaul corporate assurance, turning a costly bottleneck into a strategic engine.

A new partnership aims to solve AI's reliability problem by giving it a memory, turning scattered corporate data into a strategic, trustworthy asset.

Hivemind Capital and UC Berkeley launch darkmatter lab, a novel model to inject capital and resources into frontier research before it becomes a company.

As the Pentagon turns to Detroit to rebuild its industrial might, a key summit convenes to secure the cyber-physical systems at the heart of this revival.

Global consulting firm Protiviti secures a patent for an AI system that automates tedious compliance questionnaires, but its true innovation is keeping humans in control.

As CEO Vytautas Sinius delivers a final address, investors are looking past his legacy to the future under his successor, CFO Tomas Varenbergas.